InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Evotec SE

EVO Clue Score48
Germany Fiscal year ends December CIK 0001412558
$1.35 -1.82% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.35 −98.51% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 14 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue446.4Operating income62.7Net income38.2EPS, diluted0.25Fiscal year 2020Revenue500.9 +12.2%Operating income48.6Net income6.3 −83.5%EPS, diluted0.04 −84.0%Fiscal year 2021Revenue618.0 +23.4%Operating income41.0Net income215.5 +3,332.8%EPS, diluted1.30 +3,150.0%Fiscal year 2022Revenue751.4 +21.6%Operating income20.9Net income−175.7 −181.5%EPS, diluted−0.99 −176.2%Fiscal year 2023Revenue781.4 +4.0%Operating income−47.5Net income−83.9EPS, diluted−0.47Fiscal year 2024Revenue797.0 +2.0%Operating income−142.5Net income−196.1EPS, diluted−1.11
FY2019FY2020FY2021FY2022FY2023FY2024
Revenue 446.4 500.9 618.0 751.4 781.4 797.0
Growth +12.2% +23.4% +21.6% +4.0% +2.0%
Operating income 62.7 48.6 41.0 20.9 −47.5 −142.5
Net income 38.2 6.3 215.5 −175.7 −83.9 −196.1
Growth −83.5% +3,332.8% −181.5%
EPS, diluted 0.25 0.04 1.30 −0.99 −0.47 −1.11
Growth −84.0% +3,150.0% −176.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin29.8%Operating margin14.0%Net margin8.5%Free cash flow margin2.4%Fiscal year 2020Gross margin25.1%Operating margin9.7%Net margin1.3%Free cash flow margin−10.9%Fiscal year 2021Gross margin24.5%Operating margin6.6%Net margin34.9%Free cash flow margin1.2%Fiscal year 2022Gross margin23.2%Operating margin2.8%Net margin−23.4%Free cash flow margin3.3%Fiscal year 2023Gross margin22.4%Operating margin−6.1%Net margin−10.7%Free cash flow margin−22.6%Fiscal year 2024Gross margin14.4%Operating margin−17.9%Net margin−24.6%Free cash flow margin−12.5%
FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin 29.8% 25.1% 24.5% 23.2% 22.4% 14.4%
Operating margin 14.0% 9.7% 6.6% 2.8% −6.1% −17.9%
Net margin 8.5% 1.3% 34.9% −23.4% −10.7% −24.6%
Free cash flow margin 2.4% −10.9% 1.2% 3.3% −22.6% −12.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow42.2Capital expenditure−31.3Free cash flow10.9Fiscal year 2020Operating cash flow44.7Capital expenditure−99.1Free cash flow−54.4 −598.9%Fiscal year 2021Operating cash flow126.6Capital expenditure−118.9Free cash flow7.7Fiscal year 2022Operating cash flow205.8Capital expenditure−181.4Free cash flow24.5 +219.4%Fiscal year 2023Operating cash flow36.4Capital expenditure−213.3Free cash flow−176.9 −823.2%Fiscal year 2024Operating cash flow18.2Capital expenditure−117.5Free cash flow−99.2
FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow 42.2 44.7 126.6 205.8 36.4 18.2
Capital expenditure −31.3 −99.1 −118.9 −181.4 −213.3 −117.5
Free cash flow 10.9 −54.4 7.7 24.5 −176.9 −99.2
Growth −598.9% +219.4% −823.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2019Cash and securities277.0Shareholders’ equity478.6Fiscal year 2020Cash and securities422.6Total debt331.0Net cash (debt)91.6Shareholders’ equity724.5Debt to equity0.46Fiscal year 2021Cash and securities699.3Total debt326.3Net cash (debt)373.0Shareholders’ equity1,377.7Debt to equity0.24Fiscal year 2022Cash and securities415.2Total debt329.9Net cash (debt)85.3Shareholders’ equity1,187.2Debt to equity0.28Fiscal year 2023Cash and securities510.9Total debt130.0Net cash (debt)380.9Shareholders’ equity1,119.9Debt to equity0.12Fiscal year 2024Cash and securities306.4Total debt27.1Net cash (debt)279.3Shareholders’ equity952.5Debt to equity0.03
FY2019FY2020FY2021FY2022FY2023FY2024
Cash and securities 277.0 422.6 699.3 415.2 510.9 306.4
Total debt n/a 331.0 326.3 329.9 130.0 27.1
Net cash (debt) n/a 91.6 373.0 85.3 380.9 279.3
Shareholders’ equity 478.6 724.5 1,377.7 1,187.2 1,119.9 952.5
Debt to equity n/a 0.46 0.24 0.28 0.12 0.03

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Cash flow

In millions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Operations
42.2 44.7 126.6 205.8 36.4 18.2
Growth +5.9% +183.1% +62.6% −82.3% −50.0%
Investment
−31.3 −99.1 −118.9 −181.4 −213.3 −117.5
calc 10.9 −54.4 7.7 24.5 −176.9 −99.2
Growth −598.9% +219.4% −823.2%
−86.6 −155.1 −242.8 −412.8 −13.3 −71.2
Financing
211.3 246.4 393.0 −58.1 72.0 −161.4

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in EUR as filed; the screener converts to dollars.